Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Pharmacotherapy in Psychiatry and Neurology is Scopus-indexed (Q4, CiteScore 0.4). Published by Institute of Psychiatry and Neurology in Warsaw.
Checked against the index lists dated .
ISSN 1234-8279Verify ISSN ↗2449-9315Verify ISSN ↗
Publisher: Institute of Psychiatry and Neurology in Warsaw
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 297 / 328 | 9th | Q4 |
| Psychiatry and Mental Health | 537 / 580 | 7th | Q4 |
| Neurology | 191 / 201 | 5th | Q4 |
| Neuroscience (miscellaneous) | 71 / 74 | 4th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–2025, best quartile Q4, CiteScore 0.4.
Pharmacotherapy in Psychiatry and Neurology is Q4 in Pharmacology (rank 297 of 328), Q4 in Psychiatry and Mental Health (rank 537 of 580) and Q4 in Neurology (rank 191 of 201), by CiteScore 2025. It is ranked in 4 subject areas in all.
Pharmacotherapy in Psychiatry and Neurology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.4, quartile Q4, 9th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.124, quartile Q4, with an H-index of 2.
Pharmacotherapy in Psychiatry and Neurology is published by Institute of Psychiatry and Neurology in Warsaw. Its print ISSN is 1234-8279 and its online ISSN is 2449-9315.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Pharmacotherapy in Psychiatry and Neurology has an h-index of 5 and a 2-year mean of 0.08 citations per paper (OpenAlex). Its Scopus CiteScore is 0.4, quartile Q4. On 2-year citations it ranks #288 of 319 Scopus journals in Pharmacology.
Pharmacotherapy in Psychiatry and Neurology published 17 papers in 2025; its busiest recent year was 2020 with 33. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 71 research articles (2021–2026), authors are most often from Poland (100%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.